First Light Asset Management, LLC Q2 2017 Filing
Filed August 14, 2017
Portfolio Value
$298.1B
Holdings
55
Report Date
Q2 2017
Filing Type
13F-HR
All Holdings (55 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —AKORN INC | 732,462 | $24.6B | 8.24% | |
| 2 | NEONEOGENOMICS INC | 2,679,271 | $24.0B | 8.05% | |
| 3 | ATRCATRICURE INC | 958,858 | $23.3B | 7.80% | |
| 4 | —IMMUNOMEDICS INC | 2,048,643 | $18.1B | 6.07% | |
| 5 | OMCLOMNICELL INC | 278,294 | $12.0B | 4.02% | |
| 6 | —SHIRE PLC | 69,519 | $11.5B | 3.85% | |
| 7 | NKTREURNEKTAR THERAPEUTICS | 470,194 | $9.2B | 3.08% | |
| 8 | HBIOHARVARD BIOSCIENCE INC | 3,572,196 | $9.1B | 3.06% | |
| 9 | —OXFORD IMMUNOTEC GLOBAL PLC | 524,509 | $8.8B | 2.96% | |
| 10 | —TELIGENT INC | 948,455 | $8.7B | 2.91% | |
| 11 | —ENTELLUS MEDICAL INC | 512,416 | $8.5B | 2.85% | |
| 12 | —SPECTRANETICS CORP | 217,637 | $8.4B | 2.80% | |
| 13 | —INTERSECT ENT INC | 273,645 | $7.6B | 2.57% | |
| 14 | LGNDLIGAND PHARMACEUTICALS INC | 62,623 | $7.6B | 2.55% | |
| 15 | SG7SAGE THERAPEUTICS INC | 92,761 | $7.4B | 2.48% | |
| 16 | —K2M GROUP HOLDINGS INC | 271,495 | $6.6B | 2.22% | |
| 17 | VCYTVERACYTE INC | 754,560 | $6.3B | 2.11% | |
| 18 | LHCGUSDLHC GROUP INC | 91,917 | $6.2B | 2.09% | |
| 19 | AMEDAMEDISYS INC | 92,535 | $5.8B | 1.95% | |
| 20 | MODNEURMODEL N INC | 423,211 | $5.6B | 1.89% | |
| 21 | HALOHALOZYME THERAPEUTICS INC | 416,579 | $5.3B | 1.79% | |
| 22 | —MEDICINES COMPANY | 138,543 | $5.3B | 1.77% | |
| 23 | HRTXHERON THERAPEUTICS INC | 367,390 | $5.1B | 1.71% | |
| 24 | HSTMHEALTHSTREAM INC | 186,044 | $4.9B | 1.64% | |
| 25 | ARRYEURARRAY BIOPHARMA INC | 571,629 | $4.8B | 1.61% | |
| 26 | TECHBIO TECHNE CORP | 38,194 | $4.5B | 1.51% | |
| 27 | ENZBENZO BIOCHEM INC | 403,082 | $4.5B | 1.49% | |
| 28 | NVROEURNEVRO CORP | 59,358 | $4.4B | 1.48% | |
| 29 | —NXSTAGE MEDICAL INC | 171,578 | $4.3B | 1.44% | |
| 30 | —BLUEBIRD BIO INC | 33,780 | $3.5B | 1.19% | |
| 31 | VRTXVERTEX PHARMACEUTICALS INC | 23,119 | $3.0B | 1.00% | |
| 32 | BMRNBIOMARIN PHARMACEUTICAL INC | 31,567 | $2.9B | 0.96% | |
| 33 | IBBISHARES NASDAQ BIOTECHNOLOGY ETF | 7,097 | $2.2B | 0.74% | |
| 34 | ISIIONIS PHARMACEUTICALS INC | 42,015 | $2.1B | 0.72% | |
| 35 | QDELUSDQUIDEL CORP | 74,201 | $2.0B | 0.68% | |
| 36 | NSTGEURNANOSTRING TECHNOLOGIES INC | 114,702 | $1.9B | 0.64% | |
| 37 | —STREAMLINE HEALTH SOLUTIONS | 1,771,550 | $1.9B | 0.64% | |
| 38 | CELGCELGENE CORP | 13,701 | $1.8B | 0.60% | |
| 39 | ALKSALKERMES PLC | 29,700 | $1.7B | 0.58% | |
| 40 | —POWERSHARES S&P SMALLCAP HEALTH CARE ETF | 17,285 | $1.5B | 0.51% | |
| 41 | CDXSCODEXIS INC | 274,990 | $1.5B | 0.50% | |
| 42 | XLVHEALTH CARE SELECT SECTOR SPDR ETF | 18,241 | $1.4B | 0.48% | |
| 43 | LMATLEMAITRE VASCULAR INC | 46,234 | $1.4B | 0.48% | |
| 44 | IHIISHARES US MEDICAL DEVICES ETF | 7,580 | $1.3B | 0.42% | |
| 45 | MGNXMACROGENICS INC | 61,538 | $1.1B | 0.36% | |
| 46 | IRIXIRIDEX CORP | 100,830 | $997.0M | 0.33% | |
| 47 | XBISPDR S&P BIOTECH ETF | 9,499 | $733.0M | 0.25% | |
| 48 | —TEARLAB CORP | 420,066 | $702.0M | 0.24% | |
| 49 | SNYSANOFI-SYNTHELABO | 6,720 | $322.0M | 0.11% | |
| 50 | ABBVABBVIE | 4,159 | $302.0M | 0.10% | |
| 51 | NVSNNOVARTIS A G | 3,572 | $298.0M | 0.10% | |
| 52 | JNJJOHNSON AND JOHNSON | 2,183 | $289.0M | 0.10% | |
| 53 | PFEPFIZER INC | 8,558 | $287.0M | 0.10% | |
| 54 | DYNTQDYNATRONICS CORP | 100,000 | $280.0M | 0.09% | |
| 55 | MRKMERCK & CO INC | 4,294 | $275.0M | 0.09% |